May 10 (Reuters) - Britain's competition regulator said
on Friday it has initiated a probe into U.S. medical equipment
maker Thermo Fisher Scientific's ( TMO ) $3.1 billion deal to
buy Swedish biotech firm Olink Holding AB ( OLK ).
The Competition and Markets Authority (CMA) has set a
deadline of July 8 for its phase 1 decision.